Article: Maker to Discontinue Allergy Drug Hismanal

Hismanal, a prescription antihistamine whose sales have steadily dropped in the wake of warnings about serious side effects, is being pulled off the market, the manufacturer announced yesterday.

Janssen Pharmaceutica said the decision to stop selling Hismanal was a voluntary business decision, calling the allergy marketplace too crowded.

The decision is not a recall -- Hismanal supplies left on store shelves will continue to sell until supplies are gone, said Janssen spokesman Greg Panico. "We would advise patients who currently are taking Hismanal to consult their physicians about treatment alternatives," he said. Hismanal sales have dropped in recent years after repeated warnings from the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!